Patents by Inventor Guillaume Bort

Guillaume Bort has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220125923
    Abstract: The present invention relates to new ionizing radiation-activatable derivatives, their preparation process and their therapeutic uses.
    Type: Application
    Filed: February 7, 2020
    Publication date: April 28, 2022
    Inventors: Guillaume BORT, Patrick COUVREUR, Simona MURA, Frédéric POUZOULET
  • Patent number: 10016518
    Abstract: An imaging agent comprising a conjugate of an oligosaccharide moiety with an imaging moiety. The oligosaccharide is Lewis A or Lewis B or a mimetic thereof, or a pharmaceutically acceptable salt or PEGylated form of Lewis A or Lewis B or its mimetics. Lewis A and Lewis B and its mimetics are also provided for use in the therapeutic treatment of inflammatory diseases, autoimmune diseases and cancer.
    Type: Grant
    Filed: August 15, 2013
    Date of Patent: July 10, 2018
    Assignee: OXFORD UNIVERSITY INNOVATION LIMITED
    Inventors: Daniel Anthony, Benjamin Guy Davis, Guillaume Bort
  • Publication number: 20150231281
    Abstract: An imaging agent comprising a conjugate of an oligosaccharide moiety with an imaging moiety. The oligosaccharide is Lewis A or Lewis B or a mimetic thereof, or a pharmaceutically acceptable salt or PEGylated form of Lewis A or Lewis B or its mimetics. Lewis A and Lewis B and its mimetics are also provided for use in the therapeutic treatment of inflammatory diseases, autoimmune diseases and cancer.
    Type: Application
    Filed: August 15, 2013
    Publication date: August 20, 2015
    Inventors: Daniel Anthony, Benjamin Guy Davis, Guillaume Bort
  • Patent number: 8759331
    Abstract: The present invention relates to a X-ray and gamma-photon activable compound responding to the following formula (I). The present invention also relates to methods of synthesizing a compound according to the invention, and to an aqueous or physiological solution comprising at least one compound of the invention. The present invention also concerns a method of liberating a biologically active compound, said method involving the step of irradiating at least one compound, or at least one aqueous or physiological solution according to the invention. Finally, the present invention relates to a pharmaceutical composition comprising at least one compound, or at least one aqueous or physiological solution according to the invention.
    Type: Grant
    Filed: June 15, 2011
    Date of Patent: June 24, 2014
    Assignees: Centre National de la Recherche Scientifique, Universite Paris Descartes
    Inventors: Peter Dalko, Morgane Petit, David Ogden, Guillaume Bort, Cécile Sicard
  • Publication number: 20130190284
    Abstract: The present invention relates to a X-ray and gamma-photon activable compound responding to the following formula (I). The present invention also relates to methods of synthesizing a compound according to the invention, and to an aqueous or physiological solution comprising at least one compound of the invention. The present invention also concerns a method of liberating a biologically active compound, said method involving the step of irradiating at least one compound, or at least one aqueous or physiological solution according to the invention. Finally, the present invention relates to a pharmaceutical composition comprising at least one compound, or at least one aqueous or physiological solution according to the invention.
    Type: Application
    Filed: June 15, 2011
    Publication date: July 25, 2013
    Applicants: UNIVERSITE RENE PARIS DESCARTES, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Peter Dalko, Morgane Petit, David Ogden, Guillaume Bort, Cécile Sicard